1-20 of 1573 Search Results for


Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Article
J Health Polit Policy Law (1981) 5 (4): 593–607.
Published: 01 August 1981
...Donald R. House Policy initiated in the 1970s follows the contention that competitive forces do not work and new types of regulation are warranted. This article presents an expanded demand-supply theory introducing patient waiting time as a component of full price. Equilibrium is reached through...
Journal Article
J Health Polit Policy Law (2018) 43 (1): 5–18.
Published: 01 February 2018
...Rachel Sachs; Nicholas Bagley; Darius N. Lakdawalla Abstract In recent years, drug manufacturers and private payers have expressed interest in novel pricing models that more closely link a drug's price to its value. Indication-based pricing, outcome-based pricing, drug licenses, and drug mortgages...
Journal Article
J Health Polit Policy Law (2018) 43 (5): 771–791.
Published: 01 October 2018
...Tal Gross; Miriam J. Laugesen Abstract Higher prices are increasingly recognized as a significant cause of the outlier status of the United States in health care expenditures. At the same time, various explanations are often invoked to justify higher prices as rational or even defensible. We...
Journal Article
J Health Polit Policy Law (2006) 31 (3): 557–567.
Published: 01 June 2006
...Cara S. Lesser; Paul B. Ginsburg Drawing on observations from tracking changes in local health care markets over the past ten years, this article critiques two Federal Trade Commission and Department of Justice recommendations to enhance price and quality competition. First, we take issue...
Journal Article
J Health Polit Policy Law (2022) 47 (5): 616–619.
Published: 01 October 2022
...David L. Weimer weimer@lafollette.wisc.edu Howard Steven Friedman . Ultimate Price: The Value We Place on Life . Oakland : University of California Press . 2020 . 221 pp. $24.95 paper. Copyright © 2022 by Duke University Press 2022 Writing a book that addresses...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 621–628.
Published: 01 December 2022
... is the price of progress? That question is central to debates over regulating the pharmaceutical industry and managing spending on drugs. In recent years, there has been incredible scientific progress, illustrated by the rapid development of highly effective COVID-19 vaccines. The COVID story demonstrates...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 629–648.
Published: 01 December 2022
...Pragya Kakani; Michael Chernew; Amitabh Chandra Abstract Context: To what extent does pharmaceutical revenue growth depend on new medicines versus increasing prices for existing medicines? Moreover, does using list prices, as is commonly done, instead of prices net of confidential rebates offered...
FIGURES | View All (4)
Includes: Supplementary data
Journal Article
J Health Polit Policy Law (2022) 47 (6): 755–778.
Published: 01 December 2022
...Marc A. Rodwin Abstract This article compares the pharmaceutical pricing policies employed by public and private insurers in the United States with seven price and spending control strategies employed in the United Kingdom, France, and Germany. Differences between American and European policies...
Journal Article
J Health Polit Policy Law (1992) 17 (4): 715–738.
Published: 01 August 1992
... of health professionals does not meet the country's needs; more nursing homes are needed; and eastern Germany must be fully integrated into the system. Germany: Solidarity at a Price J...
Journal Article
J Health Polit Policy Law (1989) 14 (3): 601–620.
Published: 01 June 1989
...Gerard Wedig; Janet B. Mitchell; Jerry Cromwell Recently, budget-conscious policymakers have shifted their attention to the physician services market and have begun to consider a wide variety of price regulatory schemes for moderating expenditures in this market. In a recent article in this journal...
Journal Article
J Health Polit Policy Law (1985) 9 (4): 595–609.
Published: 01 August 1985
..., Duke University Press 1985 Reducing Public Expenditures for Physician Services: The Price of hying Less Jon R. Gabel, National Center for Health Sewices Research, and Thomas H. Rice, University of North Carolina Abstract. The purpose of this paper is to examine how physicians...
Journal Article
J Health Polit Policy Law (1988) 13 (4): 735–752.
Published: 01 August 1988
.... 1986 . Donations: Can They Reduce a Donor's Welfare? In The Economics of Nonprofit Institutions: Studies in Structure and Policy ed. S. Rose-Ackerman. New Haven, CT: Yale University Press. Research Note The Shadow Price of Pluralism: The Use of Tax...
Journal Article
J Health Polit Policy Law (1982) 7 (3): 746–748.
Published: 01 June 1982
...Richard G. Frank James W. Begun, Professionalism and the Public Interest: Price and Quality in Optometry (Cambridge, Mass.: MIT Press, 1981), 140 pp., $17.50 Copyright © 1982 by the Department of Health Administration, Duke University Press 1982 746 Journal of Heaith Politics...
Journal Article
J Health Polit Policy Law (1987) 12 (3): 409–426.
Published: 01 June 1987
...Mark S. Freeland; Sandra S. Hunt; Harold S. Luft There is a burgeoning interest in selective contracting for specialized hospital services based on volume, price, and quality. The systematic exclusion or inclusion of particular institutions has been extolled by some as an arrangement to reduce...
Published: 01 December 2022
Figure 1 Untangling the price of insulin. Notes : In arrow 1, copayment should more accurately be called plan-specified cost sharing . Source : Van Nuys 2021. More
Journal Article
J Health Polit Policy Law (2018) 43 (3): 401–425.
Published: 01 June 2018
... the incentives for continued quality improvement. Providers serving socially at-risk patients clearly fared worse in value-based pricing programs, but the overall adverse financial impact was limited. For some members of the leadership team, the positive response to program incentives, combined with less...
Journal Article
J Health Polit Policy Law (2021) 46 (6): 1053–1068.
Published: 01 December 2021
...Rachel E. Sachs Abstract Throughout his four years in office, President Trump made prescription drug pricing a focus of his policy agenda. President Trump not only used strong language to criticize the pharmaceutical industry and its practices but also introduced ambitious reform policies that had...
Journal Article
J Health Polit Policy Law (2022) 47 (4): 523–526.
Published: 01 August 2022
...Joseph White jxw87@case.edu Feldman, Robin . Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices . New York : Cambridge University Press , 2019 . 186 pp. $29.95 cloth. Copyright © 2022 by Duke University Press 2022...
Journal Article
J Health Polit Policy Law (2022) 47 (6): 779–796.
Published: 01 December 2022
...Richard Frank; Rena M. Conti; Jonathan Gruber Abstract International reference prices (IRP), also called external reference prices, are widely used across developed nations. IRP uses the prices paid in other countries to either inform negotiations with the pharmaceutical industry or as a cap...
Journal Article
J Health Polit Policy Law (2019) 44 (2): 333–339.
Published: 01 April 2019
...Jonathan Oberlander This review was commissioned by former JHPPL book review editor Rick Mayes and edited by Eric Patashnik. Miriam J. Laugesen . Fixing Medical Prices: How Physicians Are Paid . Cambridge, MA : Harvard University Press , 2016 . 288 pp. $35 , hardback...